![Daniel J. Abrams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel J. Abrams
Gründer bei Cerebral Therapeutics, Inc.
Aktive Positionen von Daniel J. Abrams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cerebral Therapeutics, Inc.
![]() Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Gründer | - | - | |
Präsident | 01.01.2010 | 24.09.2019 |
Karriereverlauf von Daniel J. Abrams
Ehemalige bekannte Positionen von Daniel J. Abrams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sierra Neuropharmaceuticals, Inc.
![]() Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Direktor/Vorstandsmitglied | 26.06.2009 | 14.04.2010 |
Technik-/Wissenschafts-/F&E-Leiter | 25.06.2009 | 19.05.2011 | |
Gründer | 14.04.2010 | 19.05.2011 | |
Präsident | 14.04.2010 | 23.02.2011 | |
University of Colorado Health Sciences Center | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 2 |
Founder | 2 |
President | 2 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sierra Neuropharmaceuticals, Inc.
![]() Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Health Technology |
Cerebral Therapeutics, Inc.
![]() Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Commercial Services |
- Börse
- Insiders
- Daniel J. Abrams
- Erfahrung